A detailed history of Centerpoint Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 83 shares of OGN stock, worth $1,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 95 12.63%
Holding current value
$1,699
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$17.45 - $21.96 $209 - $263
-12 Reduced 12.63%
83 $2,000
Q3 2023

Nov 01, 2023

SELL
$16.59 - $23.77 $149 - $213
-9 Reduced 8.65%
95 $2,000
Q4 2022

Jan 24, 2023

BUY
$23.31 - $28.61 $279 - $343
12 Added 13.04%
104 $3,000
Q2 2022

Jul 18, 2022

SELL
$31.66 - $38.9 $696 - $855
-22 Reduced 19.3%
92 $3,000
Q1 2022

Apr 27, 2022

SELL
$30.45 - $39.36 $213 - $275
-7 Reduced 5.79%
114 $4,000
Q3 2021

Oct 25, 2021

SELL
$28.63 - $35.64 $286 - $356
-10 Reduced 7.63%
121 $4,000
Q2 2021

Jul 26, 2021

BUY
$28.45 - $38.0 $3,726 - $4,978
131 New
131 $4,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.21B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.